Elsevier has pushed roughly half a million ClinicalTrials.gov entries into Embase, its subscription biomedical database.
The May 6 update lets R&D teams run a single search that pulls trial data from 200‑plus countries and matches it with Embase’s peer‑reviewed papers, in‑press manuscripts and conference abstracts.
Elsevier notes that traditional approaches to synthesizing data from multiple sources is error prone and tedious.
According to Mirit Eldor, Managing Director of Life Sciences at Elsevier, the move addresses a clear need. “Researchers are under increasing pressure to conduct comprehensive evidence searches with accuracy and efficiency, ensuring no critical information is overlooked,” Eldor stated in the announcement. “The incorporation of clinical trials data into Embase is the latest example of Elsevier’s commitment to developing innovative solutions that enhance researchers’ workflows.”
She further highlighted the practical benefits for R&D organizations: “With access to comprehensive, high-quality data, researchers can reduce time spent on manual searches, while making more informed decisions that ensure the integrity of their company’s drug, therapy, or medical device.” Eldor also noted that the integration was a direct response to user feedback, stating, “We have had many requests from customers to add Clinical Trials data into Embase and I’m delighted that we are able to improve the value that we deliver to our customers.”
Eldor said the update came straight from user requests.
Filed Under: Data science
